The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignancies

B. Faravelli, M. Nosenzo, A. Razzetti, D. Barone, E. D'Amore, R. Bandelloni, C. Gambini, P. G. Betta, A. Donna

Research output: Contribution to journalArticle

Abstract

A combined determination of pleural fluid and tissue carcinoembryonic antigen (PF-CEA and T-CEA) by radioimmunoassay and immunoperoxidase staining technique respectively was performed in patients with malignant mesotheliomas (12), metastatic pleural carcinomas (17) and benign pleural diseases (seven). All PF-CEA-positive (>39 ng/ml) cases were T-CEA-positive metastatic carcinomas. In contrast, 4 30 PF-CEA-negative (

Original languageEnglish
Pages (from-to)1083-1087
Number of pages5
JournalEuropean Journal of Cancer and Clinical Oncology
Volume21
Issue number9
DOIs
Publication statusPublished - 1985

Fingerprint

Carcinoembryonic Antigen
Pleural Diseases
Carcinoma
Immunoenzyme Techniques
Radioimmunoassay
Neoplasms
Staining and Labeling
Malignant Mesothelioma

ASJC Scopus subject areas

  • Oncology

Cite this

The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignancies. / Faravelli, B.; Nosenzo, M.; Razzetti, A.; Barone, D.; D'Amore, E.; Bandelloni, R.; Gambini, C.; Betta, P. G.; Donna, A.

In: European Journal of Cancer and Clinical Oncology, Vol. 21, No. 9, 1985, p. 1083-1087.

Research output: Contribution to journalArticle

Faravelli, B. ; Nosenzo, M. ; Razzetti, A. ; Barone, D. ; D'Amore, E. ; Bandelloni, R. ; Gambini, C. ; Betta, P. G. ; Donna, A. / The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignancies. In: European Journal of Cancer and Clinical Oncology. 1985 ; Vol. 21, No. 9. pp. 1083-1087.
@article{cf23f35801b2495dbd37ce1c40757427,
title = "The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignancies",
abstract = "A combined determination of pleural fluid and tissue carcinoembryonic antigen (PF-CEA and T-CEA) by radioimmunoassay and immunoperoxidase staining technique respectively was performed in patients with malignant mesotheliomas (12), metastatic pleural carcinomas (17) and benign pleural diseases (seven). All PF-CEA-positive (>39 ng/ml) cases were T-CEA-positive metastatic carcinomas. In contrast, 4 30 PF-CEA-negative (",
author = "B. Faravelli and M. Nosenzo and A. Razzetti and D. Barone and E. D'Amore and R. Bandelloni and C. Gambini and Betta, {P. G.} and A. Donna",
year = "1985",
doi = "10.1016/0277-5379(85)90295-0",
language = "English",
volume = "21",
pages = "1083--1087",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "9",

}

TY - JOUR

T1 - The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignancies

AU - Faravelli, B.

AU - Nosenzo, M.

AU - Razzetti, A.

AU - Barone, D.

AU - D'Amore, E.

AU - Bandelloni, R.

AU - Gambini, C.

AU - Betta, P. G.

AU - Donna, A.

PY - 1985

Y1 - 1985

N2 - A combined determination of pleural fluid and tissue carcinoembryonic antigen (PF-CEA and T-CEA) by radioimmunoassay and immunoperoxidase staining technique respectively was performed in patients with malignant mesotheliomas (12), metastatic pleural carcinomas (17) and benign pleural diseases (seven). All PF-CEA-positive (>39 ng/ml) cases were T-CEA-positive metastatic carcinomas. In contrast, 4 30 PF-CEA-negative (

AB - A combined determination of pleural fluid and tissue carcinoembryonic antigen (PF-CEA and T-CEA) by radioimmunoassay and immunoperoxidase staining technique respectively was performed in patients with malignant mesotheliomas (12), metastatic pleural carcinomas (17) and benign pleural diseases (seven). All PF-CEA-positive (>39 ng/ml) cases were T-CEA-positive metastatic carcinomas. In contrast, 4 30 PF-CEA-negative (

UR - http://www.scopus.com/inward/record.url?scp=0021929312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021929312&partnerID=8YFLogxK

U2 - 10.1016/0277-5379(85)90295-0

DO - 10.1016/0277-5379(85)90295-0

M3 - Article

C2 - 3905413

AN - SCOPUS:0021929312

VL - 21

SP - 1083

EP - 1087

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 9

ER -